Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-throughput lead finding and optimisation for GPCR targets.

A Sewing1, D Cawkill

  • 1Primary Pharmacology Group, Pfizer PDGRD, IPC 580, Ramsgate Road, CT13 9NJ Sandwich, UK. Andreas.Sewing@pfizer.com

Ernst Schering Foundation Symposium Proceedings
|August 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of different collagen modifications for titanium and titanium nitrite surfaces on functions of gingival fibroblasts.

Clinical oral investigations·2016
Same author

Cyclo-DfKRG peptide modulates in vitro and in vivo behavior of human osteoprogenitor cells on titanium alloys.

Acta biomaterialia·2009
Same author

Effect of modifications of dual acid-etched implant surfaces on peri-implant bone formation. Part I: organic coatings.

Clinical oral implants research·2009
Same author

Effect of modifications of dual acid-etched implant surfaces on periimplant bone formation. Part II: calcium phosphate coatings.

Clinical oral implants research·2009
Same author

Feasibility study using surface-enhanced Raman spectroscopy for the quantitative detection of tyrosine and serine phosphorylation.

Biochimica et biophysica acta·2007
Same author

Resonance frequency measurements of implant stability in the dog mandible: experimental comparison with histomorphometric data.

International journal of oral and maxillofacial surgery·2006
Same journal

Inhibiting Hdm2 and ubiquitin-activating enzyme: targeting the ubiquitin conjugating system in cancer.

Ernst Schering Foundation symposium proceedings·2009
Same journal

Dissecting roles of ubiquitination in the p53 pathway.

Ernst Schering Foundation symposium proceedings·2009
Same journal

Crosstalk between the SUMO and ubiquitin pathways.

Ernst Schering Foundation symposium proceedings·2009
Same journal

The ubiquitin system in health and disease. Preface.

Ernst Schering Foundation symposium proceedings·2009
Same journal

Approaches to discovering drugs that regulate E3 ubiquitin ligases.

Ernst Schering Foundation symposium proceedings·2009
Same journal

Regulation of T cell differentiation and allergic responses by the E3 ubiquitin ligase itch.

Ernst Schering Foundation symposium proceedings·2009
See all related articles

Pharmaceutical companies are advancing strategies for G-protein-coupled receptors (GPCRs) drug discovery. This involves integrated tools and knowledge for efficient small molecule optimization beyond just potency.

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Drug Discovery

Background:

  • G-protein-coupled receptors (GPCRs) are key targets in pharmaceutical research due to their roles in various physiological processes.
  • Past successes and increased understanding of signaling pathways drive GPCR focus in drug development.

Purpose of the Study:

  • To summarize advancements in the pharmaceutical industry for GPCR drug discovery.
  • To outline an efficient strategy for identifying and optimizing small molecules that modulate GPCR activity.

Main Methods:

  • Review of current assay technologies and reagent production for GPCR research.
  • Discussion of hit-to-lead processes incorporating knowledge beyond simple potency.
  • Analysis of industry-wide progress in small molecule drug design for GPCRs.

Related Experiment Videos

Main Results:

  • GPCR drug discovery requires a holistic approach combining receptor knowledge, advanced tools, and optimized processes.
  • Modern strategies emphasize broader parameters than potency, integrating recent scientific insights.
  • The pharmaceutical industry has evolved its methods for effective GPCR modulation.

Conclusions:

  • An integrated strategy is crucial for successful GPCR drug discovery and development.
  • Adapting to new knowledge and tools enhances the efficiency of finding and optimizing GPCR-targeting small molecules.
  • The field is moving towards more comprehensive approaches for modulating GPCR activity.